Cargando…
Assessing treatment adherence is crucial to determine adequacy of mineralocorticoid therapy
BACKGROUND: There is no consensus strategy for mineralocorticoid (MC) therapy titration in patients with primary adrenal insufficiency (PAI). We aim to measure serum fludrocortisone (sFC) and urine fludrocortisone (uFC) levels and to determine their utility, alongside clinical/biochemical variables...
Autores principales: | Pofi, Riccardo, Bonaventura, Ilaria, Duffy, Joanne, Maunsell, Zoe, Shine, Brian, Isidori, Andrea M, Tomlinson, Jeremy W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448575/ https://www.ncbi.nlm.nih.gov/pubmed/37410094 http://dx.doi.org/10.1530/EC-23-0059 |
Ejemplares similares
-
The Mineralocorticoid Receptor Plays a Crucial Role in Macrophage Development and Function
por: Faught, Erin, et al.
Publicado: (2023) -
MON-454 Recovery of the Hypothalamic-Pituitary-Adrenal, Gonadal, and Thyroid Axes Following Trans-Sphenoidal Adenomectomy: A Single Center Experience
por: Gunatilake, Sonali, et al.
Publicado: (2019) -
Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection
por: Isidori, Andrea M, et al.
Publicado: (2020) -
Use of contrast enhanced ultrasound in testicular diseases: A comprehensive review
por: Tenuta, Marta, et al.
Publicado: (2021) -
Mineralocorticoid hypertension
por: Gupta, Vishal
Publicado: (2011)